PARP inhibitors across different malignancies: clinical applications, resistance mechanisms, and strategies to enhance efficacy through combination therapies
- DOI
- 10.3389/fcell.2026.1891797
- Published
- 2026-09-01
- Container
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fcell.2026.1891797,
title = {PARP inhibitors across different malignancies: clinical applications, resistance mechanisms, and strategies to enhance efficacy through combination therapies},
author = {Abdelhak Ouhajjou and Omayma Mazouji and Chakib Nejjari and Roberto Incitti and Hicham Mansour},
year = {2026},
journal = {Frontiers in Cell and Developmental Biology},
doi = {10.3389/fcell.2026.1891797},
url = {https://doi.org/10.3389/fcell.2026.1891797}
}RIS
TY - JOUR TI - PARP inhibitors across different malignancies: clinical applications, resistance mechanisms, and strategies to enhance efficacy through combination therapies AU - Abdelhak Ouhajjou AU - Omayma Mazouji AU - Chakib Nejjari AU - Roberto Incitti AU - Hicham Mansour PY - 2026 JO - Frontiers in Cell and Developmental Biology DO - 10.3389/fcell.2026.1891797 UR - https://doi.org/10.3389/fcell.2026.1891797 ER -
APA
Ouhajjou, A., Mazouji, O., Nejjari, C., Incitti, R., & Mansour, H. (2026). PARP inhibitors across different malignancies: clinical applications, resistance mechanisms, and strategies to enhance efficacy through combination therapies. Frontiers in Cell and Developmental Biology. https://doi.org/10.3389/fcell.2026.1891797
Source records
- crossref · retrieved 2026-09-26T06:34:24.775Z